58°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
- Contact Us
- Subscribe
News
Sports
Features
Classifieds
Obituaries
Subscribe
E-Edition
Community Choice

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

15.51 -0.39 (-2.45%)

Streaming Delayed Price Updated: 11:59 AM EDT, May 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aurinia Pharmaceuticals Inc - Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Aurinia Pharmaceuticals: Q3 Earnings Insights ↗

November 03, 2021

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the...

Via Benzinga

Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates

November 03, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis

November 01, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

No Negative Reaction ↗

October 28, 2021

Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today.

Via Talk Markets

Analyzing Aurinia Pharmaceuticals's Unusual Options Activity ↗

August 11, 2021

Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced ...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021 ↗

October 28, 2021

Upgrades For Boot Barn Holdings Inc (NYSE:

Via Benzinga

Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021

October 27, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021

October 26, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Cyber Currency ↗

October 26, 2021

Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck.

Via Talk Markets

Aurinia Rockets — Again — On Rumored Bristol Marriage; Could Others Make A Pass? ↗

October 25, 2021

Aurinia stock hit another record Monday on Bristol's rumored takeover.

Via Investor's Business Daily

Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today ↗

October 22, 2021

The biotech is reportedly in buyout talks with Bristol Myers Squibb.

Via The Motley Fool

Aurinia Pharma Stock Pops On Reports Of Looming Bristol Myers Takeover ↗

October 22, 2021

Bristol is reportedly interested in acquiring Aurinia, according to reports that sent AUPH stock flying before it was halted.

Via Investor's Business Daily

55 Biggest Movers From Friday ↗

October 25, 2021

Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World...

Via Benzinga

More Chinese Trouble ↗

October 14, 2021

A day after the consumer price rise there was another price rise for producer markets.

Via Talk Markets

A Bit Of A Recovery ↗

September 29, 2021

While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.

Via Talk Markets

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

Pharma, Tech and Finance ↗

September 20, 2021

Good news on some drugs was not enough to boost stock markets.

Via Talk Markets

Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences

September 15, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Sunday Special ↗

September 12, 2021

I have a taste for nuclear electricity which France pioneered decades ago, building power stations along the Loire Valley and in other regions. So I took my taste for uranium into my US holdings.

Via Talk Markets

Topics Energy

Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

September 10, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Post-Rosh Hashanah, Sell? ↗

September 08, 2021

As the saying goes, sell Rosh Hashanah and buy Yom Kippur. Does it apply this year?

Via Talk Markets

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗

September 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...

Via Benzinga

Aurinia Pharmaceuticals finalizes acquisition agreement with Leading Pharma Giant

August 26, 2021

Via Get News

Aurinia Answers 'What's Next?' And Investors Punish AUPH Stock ↗

August 17, 2021

Aurinia snagged a pair of early-stage drugs for roughly $6.8 million on Tuesday, but AUPH stock tumbled into a key moving average.

Via Investor's Business Daily

Aurinia Adds Two Assets To Expand Its Immunology Pipeline ↗

August 17, 2021

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has added two assets to expand its rare autoimmune and kidney-related disease pipeline. The first program, AUR200, was...

Via Benzinga

Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases

August 17, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference

August 09, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Mid-Afternoon Market Update: Dow Gains 140 Points; Spectrum Pharmaceuticals Shares Plummet ↗

August 06, 2021

Toward the end of trading Friday, the Dow traded up 0.40% to 35,204.21 while the NASDAQ fell 0.41% to 14,833.72. The S&P also rose, gaining 0.16% to 4,435.97. The U.S. has the...

Via Benzinga

Topics Stocks

84 Biggest Movers From Friday ↗

August 09, 2021

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard Times

Services

Contact Us
Subscription Services
Promote Your Event
Site Forms
Search

ricentral.com
187 Main Street
Wakefield, RI 02879
Phone: 401-789-9744
Email: news@ricentral.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

All News about Aurinia Pharmaceuticals Inc - Common Shares

Sections

Services